Jeff Johnson
Stock Analyst at Robert W. Baird
(4.49)
# 1,056
Out of 4,456 analysts
608
Total ratings
50.6%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintained: Buy | $98 → $85 | $71.02 | +19.68% | 55 | Jun 5, 2026 | |
| ENOV Enovis | Maintained: Buy | $45 → $37 | $22.71 | +62.92% | 15 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $360 → $248 | $158.25 | +56.71% | 45 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 77.10 → CHF 73.04 | $55.20 | +32.33% | 33 | May 7, 2026 | |
| INMD InMode | Maintained: Hold | $17 → $14 | $14.63 | -4.31% | 38 | May 7, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $30 → $31 | $26.96 | +14.99% | 37 | May 7, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $104 → $97 | $84.95 | +14.18% | 56 | May 6, 2026 | |
| DXCM DexCom | Maintained: Buy | $87 → $80 | $70.14 | +14.06% | 60 | May 1, 2026 | |
| SYK Stryker | Maintained: Buy | $437 → $385 | $332.71 | +15.72% | 37 | May 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $100 → $92 | $93.10 | -1.18% | 37 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $11.01 | +27.16% | 53 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $14 | $16.82 | -16.77% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $218 | $178.43 | +22.18% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $16.24 | +84.73% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.23 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $5.95 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $109.80 | n/a | 1 | Apr 11, 2016 |
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: $98 → $85
Current: $71.02
Upside: +19.68%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $45 → $37
Current: $22.71
Upside: +62.92%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $360 → $248
Current: $158.25
Upside: +56.71%
Alcon Inc.
May 7, 2026
Maintained: Buy
Price Target: CHF 77.10 → CHF 73.04
Current: $55.20
Upside: +32.33%
InMode
May 7, 2026
Maintained: Hold
Price Target: $17 → $14
Current: $14.63
Upside: -4.31%
Envista Holdings
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $26.96
Upside: +14.99%
Henry Schein
May 6, 2026
Maintained: Buy
Price Target: $104 → $97
Current: $84.95
Upside: +14.18%
DexCom
May 1, 2026
Maintained: Buy
Price Target: $87 → $80
Current: $70.14
Upside: +14.06%
Stryker
May 1, 2026
Maintained: Buy
Price Target: $437 → $385
Current: $332.71
Upside: +15.72%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Hold
Price Target: $100 → $92
Current: $93.10
Upside: -1.18%
Feb 27, 2026
Maintained: Hold
Price Target: $12 → $14
Current: $11.01
Upside: +27.16%
Feb 18, 2026
Maintained: Hold
Price Target: $28 → $14
Current: $16.82
Upside: -16.77%
Feb 5, 2026
Maintained: Buy
Price Target: $205 → $218
Current: $178.43
Upside: +22.18%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $16.24
Upside: +84.73%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $44.23
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $67
Current: $5.95
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $109.80
Upside: n/a